These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15795325)

  • 1. Thrombosis modulates arterial drug distribution for drug-eluting stents.
    Hwang CW; Levin AD; Jonas M; Li PH; Edelman ER
    Circulation; 2005 Apr; 111(13):1619-26. PubMed ID: 15795325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents.
    Balakrishnan B; Tzafriri AR; Seifert P; Groothuis A; Rogers C; Edelman ER
    Circulation; 2005 Jun; 111(22):2958-65. PubMed ID: 15927969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local and systemic drug competition in drug-eluting stent tissue deposition properties.
    Levin AD; Jonas M; Hwang CW; Edelman ER
    J Control Release; 2005 Dec; 109(1-3):236-43. PubMed ID: 16289420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model.
    Wilson GJ; Polovick JE; Huibregtse BA; Poff BC
    Cardiovasc Res; 2007 Nov; 76(2):361-72. PubMed ID: 17716637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
    Finn AV; Kolodgie FD; Harnek J; Guerrero LJ; Acampado E; Tefera K; Skorija K; Weber DK; Gold HK; Virmani R
    Circulation; 2005 Jul; 112(2):270-8. PubMed ID: 15998681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
    Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R
    Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents.
    Mongrain R; Faik I; Leask RL; Rodés-Cabau J; Larose E; Bertrand OF
    J Biomech Eng; 2007 Oct; 129(5):733-42. PubMed ID: 17887899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall.
    Baumbach A; Herdeg C; Kluge M; Oberhoff M; Lerch M; Haase KK; Wolter C; Schröder S; Karsch KR
    Catheter Cardiovasc Interv; 1999 May; 47(1):102-6. PubMed ID: 10385171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
    J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.
    Stone GW; Ellis SG; Colombo A; Dawkins KD; Grube E; Cutlip DE; Friedman M; Baim DS; Koglin J
    Circulation; 2007 Jun; 115(22):2842-7. PubMed ID: 17515458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
    Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
    Ellis SG; Colombo A; Grube E; Popma J; Koglin J; Dawkins KD; Stone GW
    J Am Coll Cardiol; 2007 Mar; 49(10):1043-51. PubMed ID: 17349883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.